Amy O'Sullivan, PhD

Qualitative Clinical Trial Exit Interviews Evaluating Treatment Benefit, Burden, and Satisfaction in Patients With Schizophrenia

Background: An open-label extension study (NCT02873208) evaluated the long-term tolerability, safety, and efficacy of combination olanzapine/samidorphan (OLZ/SAM) treatment in patients wi...

Leona Bessonova , PhD;

Amy O'Sullivan , PhD;

David McDonnell , MD;

Cory Saucier , MPH;

Michelle White , PhD;

April Foster , BS;

Jakob Bjorner , MD, PhD;

Olga Lapeyra , MD, CCRP;

David Walling , PhD, CNS, MD;

Adam Simmons , MPH;

Julia Carpenter-Conlin , MSW;

10/08/2020

Weight Gain and Treatment Interruptions With Second-Generation Oral Antipsychotics: Analysis of Real-World Data Among Patients With Schizophrenia or Bipolar I Disorder

Among patients with schizophrenia (SZ) and bipolar I disorder (BD-I) treated with second-generation antipsychotics (SGAs), clinically-significant weight gain (CSWG) and treatment interrup...

Hannah Cummings , PhD;

Gregory Donadio , MA;

Thomas Brecht , MS;

Leona Bessonova , PhD;

Amy O'Sullivan , PhD;

David McDonnell , MD;

Jonathan Meyer , MD;

Kathleen Mortimer , ScD, MPH;

Michael Doane , PhD;

Henry Cheng , MA, MPH;

10/08/2020

Perspectives and Experiences of Individuals Living With Depression: Severity of Condition, Wellbeing, and Quality of Life

Background: Most people with depression do not achieve adequate treatment response. People’s perceptions of their depression and treatment outcomes are crucial to understanding challenges...

Andrew Nierenberg , MD, MGH;

Julia Carpenter-Conlin , MSW;

Amy O'Sullivan , PhD;

Halli Benson , MPH;

Anju Parthan , PhD;

Craig Krebsbach , MA, MS;

Phyllis Foxworth , BS;

Nikki Levy , BS ;

03/01/2019